We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human interleukin 4.
- Authors
Weiss, Geoffrey R.; Fehrenkamp, Steven H.; Tokaz, Laurence K.; Sunderland, Margaret C.; Weiss, G R; Fehrenkamp, S H; Tokaz, L K; Sunderland, M C
- Abstract
This report describes a patient with metastatic malignant melanoma treated with recombinant human interleukin 4 who developed vitiligo and severe Graves' Disease after therapy. The patient has experienced complete remission of melanoma for 49+ months. The association of antitumor response, vitiligo and thyroid disorders is reviewed.
- Publication
Dermatology (10188665), 1996, Vol 192, Issue 3, p283
- ISSN
1018-8665
- Publication type
journal article
- DOI
10.1159/000246387